Recent drug recalls in the United States from nitrosamine contamination prompt the need for more sensitive impurity testing methods and a re-evaluation of acceptable lower limit levels.
Andrew James
Advertisement
Articles by Andrew James
Advertisement
Latest Updated Articles
- Testing for Nitrosamines in Pharmaceutical Drugs
Published: June 3rd 2020 | Updated:
Advertisement
Advertisement
